Earnings Feed
Start Free
Home/Insiders/Mills Kenneth T.
MK
SEC Insider//CIK 0001652824

Mills Kenneth T.

CIK 00016528241 companyROCKVILLE, MD
SEC Profile

Transactions

50

Companies

1

Filings

6

CIK

0001652824

Recent Transactions

50 trades
  • Award
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2025-05-30+39,815→ 39,815 total
  • Award
    REGENXBIO Inc.$RGNX

    Common Stock

    2025-05-30+7,768→ 482,871 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2025-05-12$7.91/sh−20,602→ 475,103 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2025-05-12−20,602→ 0 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2025-05-12$3.76/sh+20,602→ 495,705 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2025-03-27−30,752→ 20,602 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2025-03-27$3.76/sh+30,752→ 475,103 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-08-08−36,316→ 0 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-08-08$0.85/sh+36,316→ 444,351 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-07-25$3.76/sh+15,369→ 423,404 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-07-25−15,369→ 51,354 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-07-25$13.96/sh−15,369→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-07-24$3.76/sh+12,221→ 420,256 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-07-24$13.78/sh−12,221→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-07-24−12,221→ 66,723 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-07-17$13.77/sh−2,210→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-07-17$3.76/sh+2,210→ 410,245 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-07-17−2,210→ 78,944 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-07-16$13.76/sh−200→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-07-16−200→ 81,154 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-07-16$3.76/sh+200→ 408,235 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-05-14$15.81/sh−15,000→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-05-14−15,000→ 81,354 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-05-14$3.76/sh+15,000→ 423,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-04-15−15,000→ 96,354 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-04-15$18.19/sh−15,000→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-04-15$3.76/sh+15,000→ 423,035 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-03-14$21.86/sh−15,000→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-03-14−15,000→ 111,354 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-03-14$3.76/sh+15,000→ 423,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-02-14−15,000→ 126,354 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-02-14$16.88/sh−10,348→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-02-14$3.76/sh+15,000→ 423,035 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-02-14$16.47/sh−4,652→ 418,383 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2024-01-16−45,000→ 141,354 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-01-16$15.18/sh−45,000→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-01-16$3.76/sh+45,000→ 453,035 total
  • Award
    REGENXBIO Inc.$RGNX

    Stock Options (Right to buy)

    2024-01-02+305,250→ 305,250 total
  • Tax Payment
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-01-02$17.95/sh−11,357→ 343,932 total
  • Award
    REGENXBIO Inc.$RGNX

    Common Stock

    2024-01-02+64,103→ 408,035 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2023-12-19$3.76/sh+43,500→ 398,789 total
  • Sale
    REGENXBIO Inc.$RGNX

    Common Stock

    2023-12-19$19.68/sh−45,000→ 355,289 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2023-12-19−43,500→ 186,354 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Stock Options (Right to Buy)

    2023-12-19−1,500→ 36,316 total
  • Exercise/Conversion
    REGENXBIO Inc.$RGNX

    Common Stock

    2023-12-19$0.85/sh+1,500→ 400,289 total
  • Award
    REGENXBIO Inc.$RGNX

    Stock Options (Right to buy)

    2023-01-03+264,932→ 264,932 total
  • Award
    REGENXBIO Inc.$RGNX

    Common Stock

    2023-01-03+54,753→ 355,289 total
  • Tax Payment
    REGENXBIO Inc.$RGNX

    Common Stock

    2023-01-03$22.68/sh−9,308→ 300,536 total
  • Award
    REGENXBIO Inc.$RGNX

    Stock Option (Right to Buy)

    2022-01-03+170,188→ 170,188 total
  • Award
    REGENXBIO Inc.$RGNX

    Common Stock

    2022-01-03+35,796→ 309,844 total

Companies

1

Recent Filings

6

Address

C/O REGENXBIO INC. 9804 MEDICAL CENTER DRIVE

ROCKVILLE, MD, 20850

View on SEC.gov